70.JPG)
The Single-Cell Bioinformatics Software and Services Market Size is valued at USD 267.71 Million in 2023 and is predicted to reach USD 568.90 Million by the year 2031 at a 10.3 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- Government and private investments in life sciences research, particularly in areas related to understanding complex biological systems at the single-cell level, are contributing to the growth of the market.
- Bioinformatics platforms that facilitate the integration and analysis of multi-omics data at the single-cell level are in high demand, driving market growth.
- North America dominated the market and accounted for a global revenue share in 2023.
- With the availability of bioinformatics software for single-cell analysis, many tools require expertise in programming and computational biology, which might pose a barrier to adoption for researchers without specialized training.
The single-Cell bioinformatics tool enables researchers to easily identify and explore subpopulations and differentially expressed genes while generating publication-ready figures. The sequencing software provides transcriptional profiling of numerous individual cells. This level of comprehensive throughput analysis enables researchers to comprehend, at the level of a single cell, which genes are expressed, in what amounts, and how they vary across thousands of cells in a heterogeneous sample. It will detect single-Cells genomes, transcriptomes, and other multi-omics. The software can show the differences and evolutionary relationships of various cells.
Factors responsible for the market growth are fast development in Single-Cell Technologies and Advancements in disease diagnosis and drug Discovery. In addition, biopharmaceutical companies are continuously investing in single-Cell sequencing research. Developers are updating their technologies for more detailed and user-friendly, which will boost the rapid growth of the single-Cell bioinformatics software and services market. In Jan 2022, Illumina Enters Co-Development Partnership with SomaLogic will Accelerate Next-Generation Sequencing into the Fastest-Growing Area of the Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow. The competition in sequencing software services is boosting the market's growth due to decreasing sequencing costs.
However, Barriers to Carry Out Effective Single-Cell Analysis, Analytical Challenges in Metabolite Analysis, and Lack of Spatial-Temporal Context are market growth restrainers. High capital requirements and lack of infrastructure and expertise are challenges in front of the single-Cell bioinformatics services market. On the other hand, the market also has some opportunities in the coming years as expansions continuously go into new research applications and product portfolios.
Competitive Landscape
Some Major Key Players In The Single-Cell Bioinformatics Software And Services Market:
- Illumina, Inc.,
- QIAGEN N.V.,
- BD,
- PacBio,
- Fluidigm Corporation,
- NanoString,
- Takara Bio Inc.,
- BGI,
- Oxford Nanopore Technologies plc.,
- Partek Incorporated,
- Akoya Biosciences, Inc.,
- IsoPlexis,
- Scipio Bioscience,
- Scailyte,
- BioBam Spain,
Market Segmentation
Products, applications, and end-user are the segments covered in the Global Single-Cell Bioinformatics Software and Services Market. The product segment includes bioinformatics software and bioinformatics services, which the software market will lead the segment due to competition in service providers. By application, this bioinformatics market is divided into Oncology, Immunology, Neurology, Non-invasive Prenatal Diagnosis (NIPD), Microbiology, and Other Applications. Oncological applications are increasing as several patients have cancer. Research and Academic Institutes, Biopharmaceutical Companies, and Others are subsegments of the End-User segment.
North America and Europe generate the highest revenue due to research and development advancements in the single-cell analysis services market. The demand for single-Cell RNA sequencing is more elevated in European countries, which will continue in the coming forecasting years.
Recent Developments:
- In April 2024, Takara Bio USA, Inc., the ShastaTM Single-Cell System a fully owned subsidiary of Takara Bio Inc.—was introduced. It is an automated, high-throughput NGS solution with well-validated chemistry and user-friendly bioinformatics tools that facilitate the discovery of novel biomarkers for oncology research.
Single-Cell Bioinformatics Software and Services Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 267.71 Million |
|
Revenue Forecast In 2031 |
USD 568.90 Million |
|
Growth Rate CAGR |
CAGR of 10.3 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Product, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Illumina, Inc., QIAGEN N.V., BD., PacBio, Fluidigm Corporation, NanoString, Takara Bio Inc., BGI, Oxford Nanopore Technologies plc., Partek, Incorporated, Akoya Biosciences, Inc., IsoPlexis, Scipio Bioscience, Scailyte, BioBam Spain, and other. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
